Publications
3 shownKRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors
Sotorasib showed encouraging anticancer activity in patients with heavily pretreated advanced solid tumors harboring the <i>KRAS</i> p.G12C mutation. Grade 3 or 4 treatment-rela...
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
In this phase 2 trial, sotorasib therapy led to a durable clinical benefit without new safety signals in patients with previously treated <i>KRAS</i> p.G12C-mutated NSCLC. (Fund...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 5,205
- Institution
- Queen Elizabeth Hospital
External Links
Identifiers
- ORCID
- 0000-0002-3922-2693
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.